Join Sensus Healthcare at the Fall Clinical Dermatology Conference in Las Vegas, NV October 18th – 21st, 2018. For tickets and more information click here.
Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth
Ships 21 systems including 12 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radio Therapy for Treating Non-Melanoma Skin Cancer and Keloids
SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy […]
5CC in Barcelona
Join Sensus Healthcare at the 5-Continent-Congress (5CC) in Barcelona, Spain August 30th – September 2nd, 2018. For tickets and more information click here.
Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018
BOCA RATON, Fla., July 31, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, nonsurgical “Innovator of the Year” at the 2018 Aesthetic Awards, hosted by The Aesthetic […]
Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018
Sensus Also Named Runner-Up “Company Innovator of the Year” BOCA RATON, Fla., July 31, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, […]
Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018
BOCA RATON, Fla., July 24, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, August 2, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
Is Your Blood Pressure Medicine Increasing Your Risk of Skin Cancer?
A recent study published in the Journal of American Dermatology has suggested a link between a commonly prescribed blood pressure medicine and skin cancer. Researchers at the University of Southern Denmark found that one of the most popular medicines used worldwide in the treatment of hypertension, hydrochlorothiazide (HCTZ), raises the risk of skin cancer by […]
Dr. Kevin Schewe on Colorado’s Best – Non-Surgical Technology for Skin Cancer – Alliance Cancer Care at Red Rocks
Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado’s Best on FOX network Channel 2 and Channel 31 in Denver. Watch the video here.
Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology
SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community BOCA RATON, Fla., July 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced a strategic agreement focused on marketing the […]
Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions
BOCA RATON, Fla., July 10, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide […]
People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries
Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses the importance of sun-protection and the dangers of tanning beds. She adds: “I want people to realize that it can […]
Skin Cancer and SRT – Jeff Goldstein Interview
All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer compared to the general population. Transplant patients tend to develop a skin cancer called squamous cell carcinoma (SCC) although many […]
Utilizing the SRT Keloid Treatment To Help Change Lives
The SRT Keloid Treatment helps to change lives. To show you just how effective SRT can be for keloids, we wanted to share the story of a patient who was successfully treated with the SRT-100. Tony Perkins, a teacher from St. Louis, came to Dr. Michael Jones after seeing a number of plastic surgeons for […]
Sensus Healthcare to Join Russell Microcap® Index
BOCA RATON, Fla., June 25, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]
WFN1 News – Dermatologist Dr. Ellen Turner on CEO Money
In this week’s CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radio Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate. Read the full article and listen to the interview here.
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
BOCA RATON, Fla., June 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan […]
City & Shore – Alternative Treatment to Skin Cancer Surgery
City & Shore Magazine recently wrote an article regarding the alternative treatment options to skin cancer surgery. Dr. Jason Green, DO and SRT was featured in the article. Check out the full article here.
Practical Dermatology – Solving the Keloid Conundrum
Achieving complete keloid scar removal is extremely difficult. The SRT-100 is the only FDA cleared treatment after keloid removal option on the market. Recently the machine was featured in an article on Practical Dermatology’s website. Read the full article here. Read more blogs and news here.
The Aesthetic Show
Join Sensus Healthcare at The Aesthetic Show in Las Vegas, NV July 5th – 8th, 2018. For tickets and more information click here.